It is known that the naturally occurring codons of genes encoding for an antigen and/or therapeutic protein may be suboptimal. Together with computational biologists from The Technical University of Munich, Cure Lab has developed a technology that enables the codon optimization of these genes, thereby enhancing their immunogenicity.